Papers/PMID:11211063
A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome.
Psychosomatic medicine2001The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
melatonin — decreases sleep onset latency
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Findingreplicated ×8“In the 20 patients who completed the study, sleep onset latency was significantly reduced while subjects were taking melatonin as compared with both placebo and baseline.”
Quoted verbatim from A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome.. - Study
- crossover
- Participants
- 20
- Duration
- 4 weeks
- Dose
- melatonin 5 mg, taken 19:00-21:00
- Population
- 22 patients (20 completed) with delayed sleep phase syndrome, nocturnal sleep restricted to 24:00-08:00, polysomnography
A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome.2001PMID:11211063Permalink